158 results on '"Dunn, David L."'
Search Results
2. Stool Carriage, Clinical Isolation, and Mortality during an Outbreak of Vancomycin-Resistant Enterococci in Hospitalized Medical and/or Surgical Patients
3. The Role of Anaerobic Bacteria in Intraabdominal Infections
4. Human Immunodeficiency Virus Infection in Patients with Solid-Organ Transplants: Report of Five Cases and Review
5. Devonian Chitinozoans from the Cedar Valley Formation in Iowa
6. Molecular Biology of Endotoxin Antagonism
7. Anti-Endotoxin Monoclonal Antibodies are Protective against Hepatic Ischemia/Reperfusion Injury in Steatotic Mice
8. Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: Results of a phase II trial
9. Department of Surgery, University of Minnesota, Minneapolis
10. A Prospective Randomized Trial of Steroid-Free Maintenance Regimens in Kidney Transplant Recipients—An Interim Analysis
11. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein
12. Transplant options for patients undergoing total pancreatectomy for chronic pancreatitis
13. Five preventable causes of kidney graft loss in the 1990s: A single-center analysis1
14. Pancreas after Kidney Transplants in Posturemic Patients with Type I Diabetes Mellitus
15. Rapid Discontinuation of Steroids in Living Donor Kidney Transplantation: A Pilot Study
16. Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor-mediated process
17. Endotoxin prophylaxis
18. Should I accept this kidney?
19. Six Years of Surgical Wound Infection Surveillance at a Tertiary Care Center: Review of the Microbiologic and Epidemiological Aspects of 20,007 Wounds
20. Third-Generation Cephalosporins and Vancomycin as Risk Factors for Postoperative Vancomycin-Resistant Enterococcus Infection
21. Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation
22. Risk factors for prolonged hospitalization after kidney transplants
23. A third kidney transplant: cost-effective treatment for end-stage renal disease?
24. Macrophages Expressing a Fusion Protein Derived From Bactericidal/Permeability-Increasing Protein and IgG Are Resistant to Endotoxin
25. Differential Sensitivity to Escherichia coli Infection in Mice Lacking Tumor Necrosis Factor p55 or Interleukin-1 p80 Receptors
26. Pancreas Graft Loss Caused by Intra-abdominal Infection: A Risk Factor for a Subsequent Pancreas Retransplantation
27. Do Surgeons Have a Role as Infectious Disease Consultants?
28. Bacterial Translocation in a Large-Animal Model of Small-Bowel Transplantation: Portal vs Systemic Venous Drainage and the Effect of Tacrolimus Immunosuppression
29. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus
30. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor
31. Cytomegalovirus infection and disease after solid-organ transplantation: Epidemiology, prevention, and therapy
32. Antiendotoxin Agents Share Molecular Homology within Their Lipopolysaccharide Binding Domains
33. Ganciclovir Susceptibilities of Cytomegalovirus (CMV) Isolates from Solid Organ Transplant Recipients with CMV Viremia after Antiviral Prophylaxis
34. Successful long-term outcome with 0-haplotype-matched living-related kidney donors
35. Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis
36. Bleeding Blue and Gray: Civil War Surgery and the Evolution of American Medicine
37. Invited commentary
38. Antibody Immunotherapy of Gram-negative Bacterial Sepsis
39. Scourge: The Once and Future Threat of Smallpox
40. Simulation modeling for maritime port security.
41. Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor.
42. Application Procedures for the Electromagnetic Borehole Flowmeter in Shallow Unconfined Aquifers.
43. BINDING SPECIFICITY OF POLYMYXIN B, BPI, LALF, AND ANTI-DEEP CORE/LIPID A MONOCLONAL ANTIBODY TO LIPOPOLYSACCHARIDE PARTIAL STRUCTURES.
44. Diagnosis and Treatment of Opportunistic Infections in Immunocompromised Surgical Patients.
45. Clinical characteristics of post-tranplant lymphoproliferative disorders.
46. Development and Potential Use of Antibody Directed Against Lipopolysaccharide for the Treatment of Gram-negative Bacterial Sepsis.
47. Serious bacterial infections of the skin and soft tissues.
48. Deep soft tissue infections.
49. Deep soft-tissue infections.
50. Enterococcus Infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.